218 related articles for article (PubMed ID: 37822991)
1. The Therapeutic Effects of MUC1-C shRNA@Fe
Li Z; Guo T; Zhao S; Lin M
Int J Nanomedicine; 2023; 18():5651-5670. PubMed ID: 37822991
[TBL] [Abstract][Full Text] [Related]
2. Toxicity evaluation of magnetic hyperthermia induced by remote actuation of magnetic nanoparticles in 3D micrometastasic tumor tissue analogs for triple negative breast cancer.
Stocke NA; Sethi P; Jyoti A; Chan R; Arnold SM; Hilt JZ; Upreti M
Biomaterials; 2017 Mar; 120():115-125. PubMed ID: 28056401
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
[TBL] [Abstract][Full Text] [Related]
4. Fe
Lu Q; Dai X; Zhang P; Tan X; Zhong Y; Yao C; Song M; Song G; Zhang Z; Peng G; Guo Z; Ge Y; Zhang K; Li Y
Int J Nanomedicine; 2018; 13():2491-2505. PubMed ID: 29719396
[TBL] [Abstract][Full Text] [Related]
5. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
6. Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells.
Mansur AAP; Mansur HS; Leonel AG; Carvalho IC; Lage MCG; Carvalho SM; Krambrock K; Lobato ZIP
J Mater Chem B; 2020 Aug; 8(32):7166-7188. PubMed ID: 32614035
[TBL] [Abstract][Full Text] [Related]
7. Application of biocompatible and ultrastable superparamagnetic iron(III) oxide nanoparticles doped with magnesium for efficient magnetic fluid hyperthermia in lung cancer cells.
Nowicka AM; Ruzycka-Ayoush M; Kasprzak A; Kowalczyk A; Bamburowicz-Klimkowska M; Sikorska M; Sobczak K; Donten M; Ruszczynska A; Nowakowska J; Grudzinski IP
J Mater Chem B; 2023 May; 11(18):4028-4041. PubMed ID: 36960952
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
[TBL] [Abstract][Full Text] [Related]
9. MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.
Yu B; You W; Chen G; Yu Y; Yang Q
Cell Cycle; 2019 Oct; 18(20):2641-2650. PubMed ID: 31411515
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969
[TBL] [Abstract][Full Text] [Related]
11. Glucose-Regulated Protein 78 Targeting ICG and DOX Loaded Hollow Fe
Jin Y; Cheng Z; Yuan Z; Du Y; Tian J; Shao B
Int J Nanomedicine; 2024; 19():189-208. PubMed ID: 38223882
[TBL] [Abstract][Full Text] [Related]
12. A Multifunctional, Highly Biocompatible, and Double-Triggering Caramelized Nanotheranostic System Loaded with Fe
Wang F; Li N; Wang W; Ma L; Sun Y; Wang H; Zhan J; Yu D
Int J Nanomedicine; 2023; 18():881-897. PubMed ID: 36844435
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.
Hiraki M; Suzuki Y; Alam M; Hinohara K; Hasegawa M; Jin C; Kharbanda S; Kufe D
Sci Rep; 2016 May; 6():26643. PubMed ID: 27217294
[TBL] [Abstract][Full Text] [Related]
14. Au-Fe
Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
[TBL] [Abstract][Full Text] [Related]
15. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
16. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
17. 3D in silico study of magnetic fluid hyperthermia of breast tumor using Fe
Suleman M; Riaz S
J Therm Biol; 2020 Jul; 91():102635. PubMed ID: 32716877
[TBL] [Abstract][Full Text] [Related]
18. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles.
Chauhan A; Midha S; Kumar R; Meena R; Singh P; Jha SK; Kuanr BK
Biomater Sci; 2021 Apr; 9(8):2972-2990. PubMed ID: 33635305
[TBL] [Abstract][Full Text] [Related]
19. MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells.
Yamamoto M; Jin C; Hata T; Yasumizu Y; Zhang Y; Hong D; Maeda T; Miyo M; Hiraki M; Suzuki Y; Hinohara K; Rajabi H; Kufe D
Cancer Res; 2019 Apr; 79(8):2031-2041. PubMed ID: 30824588
[TBL] [Abstract][Full Text] [Related]
20. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
